Hamakawa H - Search Results

1

Basic evidence of molecular targeted therapy for oral cancer and salivary gland cancer.

Hamakawa H, Nakashiro K, Sumida T, Shintani S, Myers JN, Takes RP, Rinaldo A, Ferlito A. Hamakawa H, et al. Head Neck. 2008 Jun;30(6):800-9. doi: 10.1002/hed.20830. Head Neck. 2008. PMID: 18429007 Review.

2

Detection of circulating cancer cells in human oral squamous cell carcinoma.

Zen H, Nakashiro K, Shintani S, Sumida T, Aramoto T, Hamakawa H. Zen H, et al. Among authors: hamakawa h. Int J Oncol. 2003 Sep;23(3):605-10. Int J Oncol. 2003. PMID: 12888894

3

Enhancement of radiosensitivity in head and neck cancer cells by ZD1839 ('IRESSA'), a selective epidermal growth factor receptor tyrosine kinase inhibitor.

Shintani S, Kiyota A, Mihara M, Sumida T, Kayahara H, Nakashiro K, Hamakawa H. Shintani S, et al. Among authors: hamakawa h. Am J Clin Oncol. 2003 Oct;26(5):e150-6. doi: 10.1097/01.coc.0000091356.25759.69. Am J Clin Oncol. 2003. PMID: 14528090

4

Gefitinib ('Iressa'), an epidermal growth factor receptor tyrosine kinase inhibitor, mediates the inhibition of lymph node metastasis in oral cancer cells.

Shintani S, Li C, Mihara M, Nakashiro K, Hamakawa H. Shintani S, et al. Among authors: hamakawa h. Cancer Lett. 2003 Nov 25;201(2):149-55. doi: 10.1016/s0304-3835(03)00464-6. Cancer Lett. 2003. PMID: 14607328

5

CD151 forms a functional complex with c-Met in human salivary gland cancer cells.

Klosek SK, Nakashiro K, Hara S, Shintani S, Hasegawa H, Hamakawa H. Klosek SK, et al. Among authors: hamakawa h. Biochem Biophys Res Commun. 2005 Oct 21;336(2):408-16. doi: 10.1016/j.bbrc.2005.08.106. Biochem Biophys Res Commun. 2005. PMID: 16139245

6

Hypoxia enhances c-Met/HGF receptor expression and signaling by activating HIF-1alpha in human salivary gland cancer cells.

Hara S, Nakashiro K, Klosek SK, Ishikawa T, Shintani S, Hamakawa H. Hara S, et al. Among authors: hamakawa h. Oral Oncol. 2006 Jul;42(6):593-8. doi: 10.1016/j.oraloncology.2005.10.016. Epub 2006 Feb 15. Oral Oncol. 2006. PMID: 16469527

7

[Clinical trial of chemotherapy identified according to chemosensitivity assay for oral cancer patients with unresectable recurrent lesions].

Shintani S, Hino S, Nakashiro K, Hamakawa H. Shintani S, et al. Among authors: hamakawa h. Gan To Kagaku Ryoho. 2006 Mar;33(3):357-60. doi: 10.2217/14750708.3.3.357. Gan To Kagaku Ryoho. 2006. PMID: 16531718 Clinical Trial. Japanese.

8

Role of Akt isoforms in HGF-induced invasive growth of human salivary gland cancer cells.

Hara S, Nakashiro K, Goda H, Hamakawa H. Hara S, et al. Among authors: hamakawa h. Biochem Biophys Res Commun. 2008 May 23;370(1):123-8. doi: 10.1016/j.bbrc.2008.03.042. Epub 2008 Mar 18. Biochem Biophys Res Commun. 2008. PMID: 18355439

9

Expression of peroxisome proliferator-activated receptor gamma and the growth inhibitory effect of its synthetic ligands in human salivary gland cancer cell lines.

Begum NM, Nakashiro K, Kawamata H, Uchida D, Shintani S, Ikawa Y, Sato M, Hamakawa H. Begum NM, et al. Among authors: hamakawa h. Int J Oncol. 2002 Mar;20(3):599-605. Int J Oncol. 2002. PMID: 11836575

10

[Non-randomized clinical study comparing chemotherapy plus radiotherapy with radiotherapy alone in neoadjuvant therapy for oral cancer].

Kayahara H, Okuda M, Terakado N, Shintani S, Hamakawa H. Kayahara H, et al. Among authors: hamakawa h. Gan To Kagaku Ryoho. 2002 Jun;29(6):911-6. Gan To Kagaku Ryoho. 2002. PMID: 12090043 Japanese.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

204 results

Search Page

Filters